Evidence map›Paper›PMID 21751053›Full record

ArticleJournal of general internal medicine2011

Income-related inequity in initiation of evidence-based therapies among patients with acute myocardial infarction.

Gillian E Hanley, Steve Morgan, Robert J Reid

Abstract read
In one paragraph

Article in Journal of general internal medicine, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Factors Associated with County-Level Variation in the Prescription of Statins.Journal of managed care & specialty pharmacy · 2019
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Gillian E HanleyCentre for Health Services and Policy Research, School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada. ghanley@chspr.ubc.ca
Steve Morgan
Robert J Reid

Funding

Canadian Institutes of Health Research
6 · The paper itself

Abstract

backgroundPrevious research has shown a socioeconomic status (SES) gradient in the receipt of cardiac services following acute myocardial infarction (AMI), but much less is known about SES and the use of secondary preventive medicines following AMI.

objectivesTo examine the role of income in initiation of treatment with ACE-inhibitors, beta-blockers and statins in the 120 days following discharge from hospital for first AMI.

designA cross-sectional study with a population-based cohort.

participantsFirst-time AMI patients between age 40 and 100 discharged alive from the hospital and surviving at least 120 days following discharge between January 1, 1999 and September 3, 2006. MAIN MEASURES: Binary variables indicating whether the patient had filled at least one prescription for each of the medicines of interest. KEY

resultsOur results reveal a significant and positive income gradient with initiation of the guideline-recommended medicines among male AMI patients. Men in the third income quintile and above were significantly more likely to initiate treatment with any of the medicines than those in the first quintile, with those in the fifth income quintile having 37%, 50% and 71% higher odds of initiating ACE-inhibitors, beta-blockers and statins, respectively, than men in the lowest income quintile [OR = 1.37 95% CI (1.24, 1.51); OR = 1.50 95% CI (1.35, 1.68); and OR = 1.71 95% CI (1.53, 190)]. The gradient was not present among women, although women in the fifth income quintile were more likely to initiate beta-blockers and statins than women in the lowest income quintile [OR = 1.25 95% CI (1.06, 1.47) and OR = 1.32 95% CI (1.12, 1.54)].

conclusionsThere were inequities in treatment following AMI in the form of a clear and often significant gradient between income and initiation of evidence-based pharmacologic therapies among male patients. This gradient persisted despite significant changes in coverage levels for the costs of these medicines.

Indexed as

Health Status DisparitiesAdrenergic beta-AntagonistsAdultAgedAged, 80 and overAge FactorsAngiotensin-Converting Enzyme InhibitorsBritish ColumbiaConfidence IntervalsCross-Sectional StudiesEvidence-Based MedicineFemaleHumansHydroxymethylglutaryl-CoA Reductase InhibitorsIncomeMaleAdrenergic beta-AntagonistsAngiotensin-Converting Enzyme InhibitorsHydroxymethylglutaryl-CoA Reductase Inhibitors

Identifiers

PMID21751053
PMCPMC3208463

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.